Novo Nordisk - 36 Year Stock Price History | NVO

Historical daily stock prices for Novo Nordisk since 1982 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Novo Nordisk (NVO) as of July 20, 2018 is 50.44.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.695B $16.962B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.643B 16.13
Pfizer (PFE) United States $222.220B 13.67
Novartis AG (NVS) Switzerland $190.657B 16.36
Merck (MRK) United States $168.566B 15.07
AbbVie (ABBV) United States $141.090B 14.39
Sanofi (SNY) France $106.218B 13.44
GlaxoSmithKline (GSK) United Kingdom $103.814B 14.19
Eli Lilly (LLY) United States $96.028B 19.07
AstraZeneca (AZN) United Kingdom $94.148B 9.86
Bristol-Myers Squibb (BMY) United States $92.695B 18.23